Junctional Epidermolysis Bullosa with Pyloric Atresia (JEBâPA)
Overview
Junctional epidermolysis bullosa with pyloric atresia (JEBâPA) is a rare, inherited disorder that combines two serious problems:
- Junctional epidermolysis bullosa (JEB): fragile skin that blisters and sloughs at the level of the dermalâepidermal junction.
- Pyloric atresia (PA):** a congenital blockage of the pylorus, the outlet of the stomach, which prevents food from passing into the small intestine.
The condition follows an autosomal recessive inheritance pattern, meaning a child must inherit a defective copy of the responsible gene from each parent.
Who is affected?
JEBâPA is seen worldwide but is most frequently reported in infants of consanguineous (related) parents. Because it is so rare, precise prevalence figures are difficult to obtain; however, epidemiologic surveys estimate that junctional EB overall occurs in roughly 1 per 200,000 live births, and JEBâPA accounts for <âŻ5âŻ% of those cases (NIH, 2020).
Typical age of onset
Signs are evident at birth or within the first few days of life. The pyloric obstruction usually presents with feeding intolerance shortly after the infant begins oral feeds.
Symptoms
Because JEBâPA affects both skin and the gastrointestinal tract, the symptom list is broader than for isolated JEB.
Skinârelated manifestations
- Blistering and erosions: tense or flaccid blisters develop after minimal trauma (e.g., diaper changes, handling).
- Granulation tissue and scarring: repeated injury leads to hypertrophic scars, especially on the hands, feet, and around joints.
- Presence of milia: small keratinâfilled cysts appear on the face and trunk.
- Onychodystrophy: nail dystrophy or loss is common.
- Hair abnormalities: alopecia or sparse, brittle hair may be noted.
- Oral mucosal lesions: blisters inside the mouth, on the tongue and palate, causing feeding difficulty.
Gastrointestinal manifestations (Pyloric Atresia)
- Projectile vomiting: nonâbilious, often begins within the first 24â48âŻhours after birth once feeds are introduced.
- Failure to thrive: poor weight gain due to inability to ingest and absorb nutrients.
- Dehydration and electrolyte imbalance: secondary to persistent vomiting.
- Abdominal distention: may be modest because the obstruction is proximal.
Other systemic features
- Respiratory involvement: rare, but some infants develop airway mucosal fragility.
- Renal abnormalities: occasional reports of renal tubular dysfunction, likely secondary to genetic defect.
Causes and Risk Factors
JEBâPA results from mutations that disrupt the proteins anchoring the epidermis to the basement membrane and, concurrently, affect the development of the pyloric muscle.
Genetic basis
- ITGA6 (α6 integrin) and ITGB4 (ÎČ4 integrin) genes: Most cases involve biallelic lossâofâfunction mutations in these genes (CDC).
- LAMA3, LAMB3, LAMC2: Rarely, mutations in lamininâ332 subunits produce a similar phenotype.
Inheritance pattern
Autosomal recessive â each parent is typically an asymptomatic carrier. The risk for each subsequent pregnancy is 25âŻ%.
Risk factors
- Consanguineous marriage (firstâcousin or closer).
- Family history of epidermolysis bullosa or unexplained neonatal gastric obstruction.
- Certain ethnic groups with higher carrier frequencies (e.g., some MiddleâEastern and SouthâAsian populations).
Diagnosis
Early recognition is crucial because the gastrointestinal obstruction can be lifeâthreatening, and skin care must be instituted promptly.
Clinical evaluation
- Detailed birth and family history, focusing on consanguinity and prior affected siblings.
- Physical examination noting blister distribution, presence of milia, and signs of pyloric obstruction (nonâbilious vomiting, upper abdominal fullness).
Laboratory and imaging studies
- Abdominal ultrasound: reveals a distended stomach with an absent or narrowed pyloric canal.
- Upper gastrointestinal (GI) contrast study: classic âsingle bubbleâ sign confirming pyloric atresia.
- Skin biopsy with immunofluorescence mapping (IFM): shows absent or reduced expression of α6ÎČ4 integrin at the basement membrane.
- Genetic testing: targeted gene panels or wholeâexome sequencing to identify pathogenic variants in ITGA6, ITGB4, or related genes.
Additional assessments
- Baseline electrolyte panel and renal function tests (due to risk of dehydration and possible renal involvement).
- Ophthalmology and dental evaluations, as mucosal fragility can affect eyes and teeth.
Treatment Options
There is no cure; management focuses on supportive care, preventing complications, and addressing the pyloric blockage.
1. Surgical correction of pyloric atresia
- Pyloroplasty or gastroâjejunostomy: Performed within the first weeks of life to restore gastric outflow. Success rates exceed 90âŻ% when performed by experienced pediatric surgeons (Cleveland Clinic).
- Postâoperative nutritional support (parenteral or enteral) until the infant tolerates feeds.
2. Skin care and wound management
- Gentle handling: Use soft bedding, avoid adhesive tapes, and handle the infant with lintâfree gloves.
- Barrier creams and emollients: Petrolatumâbased ointments protect intact skin; avoid petroleumâjelly on open wounds.
- Nonâadhesive dressings: Silicone, hydrocolloid, or MepilexÂź dressings reduce pain and trauma.
- Infection control: Topical antimicrobials (e.g., mupirocin) for colonized wounds; systemic antibiotics only when infection is proven.
- Pain management: Acetaminophen, ibuprofen (if renal function allows), or lowâdose opioid regimens under specialist guidance.
3. Nutritional support
- Highâcalorie, proteinârich formulas once oral intake is possible.
- If oral feeding is limited by oral mucosal blisters, consider nasogastric feeding or gastrostomy tube after surgical repair.
4. Pharmacologic therapies
- Systemic retinoids (e.g., acitretin): May reduce blister formation in some JEB subtypes but have limited evidence in JEBâPA and carry hepatotoxicity risks; use only in specialist centers.
- Antifibrotic agents (e.g., tranexamic acid): Occasionally employed to limit scar formation, though data are anecdotal.
5. Multidisciplinary followâup
Optimal care involves a team: pediatric dermatologist, pediatric surgeon, gastroenterologist, nutritionist, genetic counselor, and psychosocial support services.
Living with Junctional Epidermolysis Bullosa with Pyloric Atresia
Families adapt to a lifelong condition that requires vigilance and routine care.
Daily skin care routine
- Gently cleanse with lukewarm water and a mild, fragranceâfree cleanser.
- Pat dryâdo not rub.
- Apply a thin layer of barrier ointment within 5âŻminutes of drying.
- Cover new blisters with nonâadhesive dressings; change dressings daily or sooner if saturated.
Feeding & nutrition
- Offer small, frequent feeds after surgical repair.
- Monitor weight daily for the first 3âŻmonths; aim for a gain of 20â30âŻg/day.
- Consider a dietitianâsupervised highâenergy formula if weight gain stalls.
Home environment modifications
- Use soft, breathable clothing (cotton, bamboo); avoid wool, synthetic fibers, and tight elastic bands.
- Keep nails trimmed to prevent accidental scratching.
- Maintain a cool, humidityâcontrolled room to reduce skin drying.
Psychosocial support
- Connect with patient advocacy groups such as the Dystrophic Epidermolysis Bullosa Research Association (DEBRA).
- Seek counseling for parentsâchronic illness can lead to caregiver burnout.
- Schoolâage children benefit from individualized education plans (IEPs) that address skinâcare needs and possible anxiety.
Prevention
Because JEBâPA is genetic, primary prevention focuses on informed reproductive choices.
- Carrier screening: Couples with known family history or from highârisk populations should consider preâconception genetic testing for ITGA6/ITGB4 mutations.
- Prenatal diagnosis: Chorionic villus sampling (CVS) or amniocentesis with targeted molecular analysis can detect pathogenic variants.
- Preâimplantation genetic diagnosis (PGD): For couples undergoing inâvitro fertilization, embryos without the diseaseâcausing mutations can be selected.
- Avoid skin trauma: While it does not prevent the genetic disease, minimizing friction injuries reduces blister burden and secondary infection.
Complications
If inadequately managed, JEBâPA can lead to serious, sometimes lifeâthreatening sequelae.
- Sepsis: Open skin wounds are portals for bacteria; bloodstream infection is a leading cause of mortality in severe EB.
- Malnutrition and growth failure: Persistent vomiting, feeding difficulties, and increased metabolic demands.
- Severe anemia: Chronic blood loss from skin erosions.
- Hypertrophic scarring and contractures: May restrict joint motion and require physiotherapy or surgical release.
- Renal insufficiency: Reported in a minority of patients, possibly linked to integrin dysfunction.
- Psychological impact: Depression, anxiety, and social isolation are common without adequate support.
When to Seek Emergency Care
- Sudden, profuse vomiting that does not improve with positioning.
- Signs of dehydration â dry mouth, sunken eyes, absence of tears, or a sudden drop in urine output.
- FeverâŻâ„âŻ38âŻÂ°C (100.4âŻÂ°F) accompanied by worsening skin blisters or foulâsmelling discharge.
- Rapid heart rate (>âŻ180âŻbpm in infants) or breathing difficulties.
- Sudden increase in size of a blister that becomes extremely painful, tense, or turns purple/black (possible infection or compartment syndrome).
- Any bleeding that cannot be stopped with gentle pressure.
© 2026 HealthGuide Corp. All information provided is for educational purposes and should not replace personalized medical advice. Consult your healthcare provider for diagnosis and treatment tailored to your situation.